About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- gadoxetic acid disodium
- Procedure number
- PSUSA/00001509/202304
- Regulatory outcome
- Variation
Documents
Gadoxetic acid disodium : List of nationally authorised medicinal products - PSUSA/00001509/202304
English (EN) (419.01 KB - PDF)
Gadoxetic acid disodium : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00001509/202304
English (EN) (26.16 KB - PDF)
български (BG) (161.65 KB - PDF)
español (ES) (26.39 KB - PDF)
čeština (CS) (165.01 KB - PDF)
dansk (DA) (86.48 KB - PDF)
Deutsch (DE) (27.06 KB - PDF)
eesti keel (ET) (126.01 KB - PDF)
ελληνικά (EL) (161.11 KB - PDF)
français (FR) (133.65 KB - PDF)
hrvatski (HR) (158.61 KB - PDF)
íslenska (IS) (26.01 KB - PDF)
Gaeilge (GA) (27.15 KB - PDF)
italiano (IT) (131.1 KB - PDF)
latviešu valoda (LV) (198.94 KB - PDF)
lietuvių kalba (LT) (161.61 KB - PDF)
magyar (HU) (132.54 KB - PDF)
Malti (MT) (141.56 KB - PDF)
Nederlands (NL) (86.24 KB - PDF)
norsk (NO) (85.97 KB - PDF)
polski (PL) (164.89 KB - PDF)
português (PT) (27.26 KB - PDF)
română (RO) (129.58 KB - PDF)
slovenčina (SK) (141.49 KB - PDF)
slovenščina (SL) (158.3 KB - PDF)
Suomi (FI) (80.83 KB - PDF)
svenska (SV) (27.32 KB - PDF)